George Yancopoulos, President and Chief Scientific at REGENERON PHARMACEUTICALS, INC. (REGN), sold 26,378 shares at $800.08 ($21.1M) on 2023-02-06, disclosed to the SEC on 2023-02-08.
Open-market sale of $21.1M REGN by President and Chief Scientific. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $800.08 | 13,189 | $10.6M | 50.0% |
| 2 | $800.08 | 13,189 | $10.6M | 50.0% |
| Total | $800.08 avg | 26,378 | $21.1M | 100% |
| Filing → |
| REGN | SELL | 2024-01-04 | $15.2M | — | Filing → |
| REGN | SELL | 2023-03-27 | $5.0M | — | Filing → |
| REGN | SELL | 2021-08-17 | $62.0M | — | Filing → |